U3 Pharma AG
Apr 09, 02
08:06 ET
U3 Pharma Scientific Founder, Axel Ullrich, Presents Data on Novel Signal Transduction Cancer Target at AACR
Jan 24, 02
12:55 ET
U3 Pharma Appoints Dr. Karsten Henco, Dr. Jean Deleage and Prof. Axel Ullrich To Supervisory Board
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A
United Business Media
company.